Tobias Engler

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 21

Top Topics

Squamous Cell Carcinoma

Early Breast Cancer

Prognostic Factors

Neoadjuvant Chemotherapy

Top Venues

International journal of molecular sciences

Journal of personalized medicine

Journal of medical Internet research

This page only lists publications with an associated author ORCID identifier.

Publications

Dominik Dannehl, Alexandra von Au, Tobias Engler, Léa Louise Volmer, Raphael Gutsfeld, Johannes Felix Englisch, Markus Hahn, Sabine Hawighorst-Knapstein, Ariane Chaudhuri, Armin Bauer, Markus Wallwiener, Florin-Andrei Taran, Diethelm Wallwiener, Sara Yvonne Brucker, Stephanie Wallwiener, Andreas Daniel Hartkopf, Tjeerd Maarten Hein Dijkstra
Implementation and Evaluation of a Breast Cancer Disease Model Using Real-World Claims Data in Germany from 2010 to 2020. Cancers 16 (8) (2024)
Anna Seller, Christian Martin Tegeler, Jonas Mauermann, Tatjana Schreiber, Ilona Hagelstein, Kai Liebel, André Koch, Jonas S Heitmann, Sarah M Greiner, Clara Hayn, Dominik Dannehl, Tobias Engler, Andreas Daniel Hartkopf, Markus Hahn, Sara Yvonne Brucker, Helmut R Salih, Melanie Märklin
Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome. International journal of molecular sciences 25 (7) (2024)
Anna Seller, Christian Martin Tegeler, Jonas Mauermann, Tatjana Schreiber, Ilona Hagelstein, Kai Liebel, André Koch, Jonas S Heitmann, Sarah M Greiner, Clara Hayn, Dominik Dannehl, Tobias Engler, Andreas Daniel Hartkopf, Markus Hahn, Sara Yvonne Brucker, Helmut R Salih, Melanie Märklin
Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome. International journal of molecular sciences 25 (7) (2024)
Léa Louise Volmer, Dominik Dannehl, Sabine Matovina, Florin-Andrei Taran, Christina Barbara Walter, Markus Wallwiener, Sara Yvonne Brucker, Andreas Daniel Hartkopf, Tobias Engler
Comparing the HER2 Status of the Primary Tumor to That of Disseminated Tumor Cells in Early Breast Cancer. International journal of molecular sciences 25 (11) (2024)
Dominik Dannehl, Alexandra von Au, Tobias Engler, Léa Louise Volmer, Raphael Gutsfeld, Johannes Felix Englisch, Markus Hahn, Sabine Hawighorst-Knapstein, Ariane Chaudhuri, Armin Bauer, Markus Wallwiener, Florin-Andrei Taran, Diethelm Wallwiener, Sara Yvonne Brucker, Stephanie Wallwiener, Andreas Daniel Hartkopf, Tjeerd Maarten Hein Dijkstra
Implementation and Evaluation of a Breast Cancer Disease Model Using Real-World Claims Data in Germany from 2010 to 2020. Cancers 16 (8) (2024)
Léa Louise Volmer, Dominik Dannehl, Sabine Matovina, Florin-Andrei Taran, Christina Barbara Walter, Markus Wallwiener, Sara Yvonne Brucker, Andreas Daniel Hartkopf, Tobias Engler
Comparing the HER2 Status of the Primary Tumor to That of Disseminated Tumor Cells in Early Breast Cancer. International journal of molecular sciences 25 (11) (2024)
Hannes Armbruster, Tilman Schotte, Isabell Götting, Mathis Overkamp, Massimo Granai, Lea Louise Volmer, Veronika Bahlinger, Sabine Matovina, André Koch, Dominik Dannehl, Tobias Engler, Andreas Daniel Hartkopf, Sara Yvonne Brucker, Irina Bonzheim, Falko Fend, Annette Staebler, Ivonne-Aidee Montes-Mojarro
Aberrant p53 immunostaining patterns in breast carcinoma of no special type strongly correlate with presence and type of TP53 mutations. Virchows Archiv : an international journal of pathology (2024)
Anna Seller, Christian Martin Tegeler, Jonas Mauermann, Tatjana Schreiber, Ilona Hagelstein, Kai Liebel, André Koch, Jonas S Heitmann, Sarah M Greiner, Clara Hayn, Dominik Dannehl, Tobias Engler, Andreas Daniel Hartkopf, Markus Hahn, Sara Yvonne Brucker, Helmut R Salih, Melanie Märklin
Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome. International journal of molecular sciences 25 (7) (2024)
Léa Louise Volmer, Dominik Dannehl, Sabine Matovina, Florin-Andrei Taran, Christina Barbara Walter, Markus Wallwiener, Sara Yvonne Brucker, Andreas Daniel Hartkopf, Tobias Engler
Comparing the HER2 Status of the Primary Tumor to That of Disseminated Tumor Cells in Early Breast Cancer. International journal of molecular sciences 25 (11) (2024)
Sebastian Werner, Julia Sekler, Brigitte Gückel, Christian Peter la Fougère, Konstantin Nikolaou, Christina Pfannenberg, Heike Preibsch, Tobias Engler, Susann-Cathrin Olthof
Influence of [ 18 F]FDG-PET/CT on Clinical Management Decisions in Breast Cancer Patients-A PET/CT Registry Study. Diagnostics (Basel, Switzerland) 13 (14) (2023)
Cansu E Önder, Teresa J Ziegler, Ronja Becker, Sara Yvonne Brucker, Andreas Daniel Hartkopf, Tobias Engler, André Koch
Advancing Cancer Therapy Predictions with Patient-Derived Organoid Models of Metastatic Breast Cancer. Cancers 15 (14) (2023)
Dominik Dannehl, Tobias Engler, Léa Louise Volmer, Christian Martin Tegeler, Julia Fusshoeller, Emma Gabrysch, Kenneth Eissler, Anna Seller, Eva-Maria Grischke, Markus Hahn, Ines Gruber, Fabienne Schochter, Kerstin Pfister, Kristina Veselinovic, Elena Leinert, Brigitte Rack, Visnja Fink, Wolfgang Janni, Sara Yvonne Brucker, Andreas Daniel Hartkopf, Henning Schäffler
Which Patients Do We Need to Test for BRCA1/2 Mutation? Feasibility of Adjuvant Olaparib Treatment in Early Breast Cancer-Real-World Data from Two Large German Breast Centers. Cancers 15 (15) (2023)
Polina Kaidun, Samuel J Holzmayer, Sarah M Greiner, Anna Seller, Christian Martin Tegeler, Ilona Hagelstein, Jonas Mauermann, Tobias Engler, André Koch, Andreas Daniel Hartkopf, Helmut R Salih, Melanie Märklin
Targeting NKG2DL with Bispecific NKG2D-CD16 and NKG2D-CD3 Fusion Proteins on Triple-Negative Breast Cancer. International journal of molecular sciences 24 (17) (2023)
Henning Schäffler, Franziska Mergel, Kerstin Pfister, Stephan Lukac, Angelina Fink, Kristina Veselinovic, Brigitte Rack, Visnja Fink, Elena Leinert, Moritz Dimpfl, Alexander Englisch, Christian Martin Tegeler, Anna Seller, Eva-Maria Grischke, Markus Hahn, Léa Louise Volmer, Tobias Engler, Marie Louise Frevert, Florin-Andrei Taran, Wolfgang Janni, Sara Yvonne Brucker, Andreas Daniel Hartkopf, Dominik Dannehl
The Clinical Relevance of the NATALEE Study: Application of the NATALEE Criteria to a Real-World Cohort from Two Large German Breast Cancer Centers. International journal of molecular sciences 24 (22) (2023)
Florin-Andrei Taran, Jana Pasternak, Annette Staebler, Annika Rohner, Felix Neis, Tobias Engler, Ernst Oberlechner, Birgitt Schönfisch, Ingolf Juhasz-Böss, Andreas Daniel Hartkopf, Sara Yvonne Brucker, Christina Barbara Walter
Tumor-Free Resection Margin Distance in the Surgical Treatment of Node-Negative Squamous Cell Cancer of the Vulva Has No Impact on Survival: Analysis of a Large Patient Cohort in a Tertiary Care Center. Cancers 15 (16) (2023)
Léa L Volmer, Cansu E Önder, Barbara Volz, Anjali R Singh, Sara Yvonne Brucker, Tobias Engler, Andreas Daniel Hartkopf, André Koch
Microfluidic Isolation of Disseminated Tumor Cells from the Bone Marrow of Breast Cancer Patients. International journal of molecular sciences 24 (18) (2023)
Léa Volmer, André Koch, Sabine Matovina, Dominik Dannehl, Martin Weiss, Ganna Welker, Markus Hahn, Tobias Engler, Markus Wallwiener, Christina Barbara Walter, Ernst Oberlechner, Sara Yvonne Brucker, Klaus Pantel, Andreas Hartkopf
Neoadjuvant Chemotherapy of Patients with Early Breast Cancer Is Associated with Increased Detection of Disseminated Tumor Cells in the Bone Marrow. Cancers 14 (3) (2022)
Joachim Graf, Nina Sickenberger, Katharina Brusniak, Lina Maria Matthies, Thomas Maximilian Deutsch, Elisabeth Simoes, Claudia Plappert, Lucia Keilmann, Andreas Daniel Hartkopf, Christina Barbara Walter, Markus Hahn, Tobias Engler, Stephanie Wallwiener, Florian Schuetz, Peter Andreas Fasching, Andreas Schneeweiß, Sara Yvonne Brucker, Markus Wallwiener
Implementation of an Electronic Patient-Reported Outcome App for Health-Related Quality of Life in Breast Cancer Patients: Evaluation and Acceptability Analysis in a Two-Center Prospective Trial. Journal of medical Internet research 24 (2) (2022)
Dominik Dannehl, Lea L Volmer, Martin Weiss, Sabine Matovina, Eva-Maria Grischke, Ernst Oberlechner, Anna Seller, Christina B Walter, Markus Hahn, Tobias Engler, Sara Yvonne Brucker, Andreas D Hartkopf
Feasibility of Adjuvant Treatment with Abemaciclib-Real-World Data from a Large German Breast Center. Journal of personalized medicine 12 (3) (2022)
Dominik Dannehl, Tobias Engler, Lea L Volmer, Annette Staebler, Anna Katharina Fischer, Martin Weiss, Markus Hahn, Christina B Walter, Eva-Maria Grischke, Falko Fend, Florin-Andrei Taran, Sara Yvonne Brucker, Andreas D Hartkopf
Recurrence Score ® Result Impacts Treatment Decisions in Hormone Receptor-Positive, HER2-Negative Patients with Early Breast Cancer in a Real-World Setting-Results of the IRMA Trial. Cancers 14 (21) (2022)
Katharina Brusniak, Manuel Feisst, Linda Sebesteny, Andreas Daniel Hartkopf, Joachim Graf, Tobias Engler, Andreas Schneeweiß, Markus Wallwiener, Thomas Maximilian Deutsch
Measuring the Time to Deterioration for Health-Related Quality of Life in Patients With Metastatic Breast Cancer Using a Web-Based Monitoring Application: Longitudinal Cohort Study. JMIR cancer 7 (4) (2021)